Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=O'Harte, Finbarr P. M.$<.>)
Общее количество найденных документов : 20
Показаны документы с 1 по 20
1.
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion // Diabetes, 1996. Vol. 45, N 8.-С.1132-1140

2.
Vitamin C supplementation ameliorates aspects of the diabetic syndrome in obese hyperglycaemic (ob/ob) mice // Proc. Nutr. Soc., 1997. Vol. 56, N 1a.-С.46A

3.
Vitamin C supplementation ameliorates aspects of the diabetic syndrome in obese hyperglycaemic (ob/ob) mice // Proc. Nutr. Soc., 1997. Vol. 56, N 1a.-С.46A

4.
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion // Diabetes, 1996. Vol. 45, N 8.-С.1132-1140

5.
Glycation of insulin in the islets of Langerhans of normal and diabetic animals // Diabetes, 1996. Vol. 45, N 11.-С.1489-1496

6.
Purification and characterization of insulin, glucagon, and two glucagon-like peptides with insulin-releasing activity from the pancreas of the toad, Bufo marinus // Endocrinology, 1998. Vol. 139, N 8.-С.3442-3448

7.
Pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes // Proc. Nutr. Soc., 1997. Vol. 56, N 1b.-С.243-262

8.
Pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes // Proc. Nutr. Soc., 1997. Vol. 56, N 1b.-С.243-262

9.
O'Harte Finbarr P.M. NH[2]-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity // Diabetes, 1999. Vol. 48, N 4.-С.758-765

10.
O'Harte Finbarr P.M. NH[2]-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity // Diabetes, 1999. Vol. 48, N 4.-С.758-765

11.
O'Harte Finbarr P.M. NH[2]-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity // Diabetes, 1999. Vol. 48, N 4.-С.758-765

12.
Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models // Biochim. et biophys. acta. Gen. Subj., 2002. Vol. 1569, N 1-3.-С.75-80

13.
N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo // Biochim. et biophys. acta. Gen. Subj., 2000. Vol. 1474, N 1.-С.13-22

14.
N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo // Biochim. et biophys. acta. Gen. Subj., 2000. Vol. 1474, N 1.-С.13-22

15.
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro{3}) GIP receptor antagonist in type 2 diabetes // Biol. Chem., 2007. Vol. 388, N 2.-С.173-179

16.
A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL{16}), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones // Biol. Chem., 2006. Vol. 387, N 7.-С.941-947

17.
Novel glucagon-like peptide-1 (GLP-1) analog (Val{8}) GLP-1 results in significant improvements of glucose tolerance and pancreatic 'бета'-cell function after 3-week daily administration in obese diabetic (ob/ob) mice // J. Pharmacol. and Exp. Ther., 2006. Vol. 318, N 2.-С.914-921

18.
Novel glucagon-like peptide-1 (GLP-1) analog (Val{8}) GLP-1 results in significant improvements of glucose tolerance and pancreatic 'бета'-cell function after 3-week daily administration in obese diabetic (ob/ob) mice // J. Pharmacol. and Exp. Ther., 2006. Vol. 318, N 2.-С.914-921

19.
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties // Biochem. Pharmacol., 2009. Vol. 78, N 8.-С.1008-1016

20.
Ablation of glucagon receptor signaling by peptide-based glucagon antagonists improves glucose tolerance in high fat fed mice // Peptides, 2014. Vol. 60.-С.95-101

 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)